Keefe, Bruyette & Woods Boosts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $20.00

Crescent Capital BDC (NASDAQ:CCAPFree Report) had its price target boosted by Keefe, Bruyette & Woods from $19.00 to $20.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an outperform rating on the stock.

Several other brokerages have also recently commented on CCAP. LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 price target for the company. Bank of America lowered their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. Finally, Wells Fargo & Company dropped their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Crescent Capital BDC has a consensus rating of “Moderate Buy” and a consensus price target of $19.17.

Get Our Latest Stock Report on Crescent Capital BDC

Crescent Capital BDC Price Performance

Shares of CCAP stock opened at $19.29 on Monday. The firm has a market cap of $714.93 million, a price-to-earnings ratio of 7.56 and a beta of 0.81. Crescent Capital BDC has a 12 month low of $15.91 and a 12 month high of $19.63. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. The stock has a 50-day moving average price of $18.57 and a 200 day moving average price of $18.52.

Crescent Capital BDC Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 8.71%. The ex-dividend date is Tuesday, December 31st. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.

Hedge Funds Weigh In On Crescent Capital BDC

Several institutional investors and hedge funds have recently made changes to their positions in the company. Point72 Asset Management L.P. acquired a new stake in Crescent Capital BDC during the 2nd quarter worth $90,000. XTX Topco Ltd acquired a new stake in shares of Crescent Capital BDC during the second quarter worth about $195,000. Catalina Capital Group LLC acquired a new stake in shares of Crescent Capital BDC during the second quarter worth about $220,000. Cubist Systematic Strategies LLC bought a new position in shares of Crescent Capital BDC during the 2nd quarter valued at about $346,000. Finally, Van ECK Associates Corp grew its position in shares of Crescent Capital BDC by 136.1% in the 2nd quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock valued at $498,000 after purchasing an additional 15,288 shares during the period. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Further Reading

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.